|
65679f6d212eaade2e0f055c
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20170085940002
|
108594
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.023643
|
0
|
0
|
0
|
0.023643
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
UNDERSTANDING THE ROLE OF TYPE... 1 INTERFERON IN RESISTANCE TO CANCER IMMUNOTHERAPY
more
|
Understanding the role of type... 1 interferon in resistance to cancer immunotherapy
more
|
Chemotherapy is the main form ...of treatment for cancer, but it cannot cure most types of cancer. Another form of treatment is immunotherapy, which aims to stimulate cells of the body's immune system (T cells) to kill cancer cells. Unfortunately, cancers may become resistant to T cells in the same way they learned to resist chemotherapy. This resistance is partly caused by a blood protein called interferon. This project aims to improve the effectiveness of cancer immunotherapy. Based on previous work, the research team will investigate the use of interferon inhibitors to treat cancer cells from patients with leukemia. This approach is expected to increase cure rates with immunotherapy in leukemia and many other forms of cancer. Moreover, the results of this study can open the path to the development of new and innovative cancer drugs based on interferon inhibition.The project is led in Canada by the Sunnybrook Research Institute-University of Toronto in collaboration with the Weizmann Institute of Science (Israel), and Jilin University (China). This project was selected for funding through the third research competition of the Joint Canada-Israel Health Research Program, a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
21000
|
International NGO
|
Sunnybrook Research Institute
|
|
|
|
65679f6d212eaade2e0f055d
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091500006
|
109150
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.022547
|
0
|
0
|
0
|
0.022547
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMMUNOMETABOLIC ROLES AND THER...APEUTIC POTENTIAL OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
more
|
Immunometabolic roles and ther...apeutic potential of glucose-dependent insulinotropic polypeptide (GIP)
more
|
Obesity, type 2 diabetes, and ...cardiovascular disease share common features, including inflammation in multiple tissues. Inflammation arising in the context of diabetes or obesity is thought to contribute to some of the complications of these disorders, including increased risk of cancer and, most notably, higher rates of heart attacks and strokes. Inflammation may arise in part from the gut, which harbours bacterial organisms and products. Inflammation in turn induces the secretion of some gut peptides — hormonal messengers that relay signals from the gut to distant tissues, including immune cells. Preliminary data suggest that the increased action of a gut hormone known as glucose-dependent insulinotropic polypeptide (GIP) suppresses inflammation, whereas reduced or complete absence of GIP has the contrary effect, with adverse consequences for metabolism and accelerated development of atherosclerosis. There are currently multiple drug development programs under way to explore whether modulation of GIP activity might be a useful therapeutic approach to treat metabolic disorders such as diabetes and obesity. This project aims to understand how GIP controls inflammation in adipose tissue immune cells and in blood vessels susceptible to the development of atherosclerosis. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Sinai Health System
|
|
|
|
65679f6d212eaade2e0f055e
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091500005
|
109150
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.019207
|
0
|
0
|
0
|
0.019207
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMMUNOMETABOLIC ROLES AND THER...APEUTIC POTENTIAL OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
more
|
Immunometabolic roles and ther...apeutic potential of glucose-dependent insulinotropic polypeptide (GIP)
more
|
Obesity, type 2 diabetes, and ...cardiovascular disease share common features, including inflammation in multiple tissues. Inflammation arising in the context of diabetes or obesity is thought to contribute to some of the complications of these disorders, including increased risk of cancer and, most notably, higher rates of heart attacks and strokes. Inflammation may arise in part from the gut, which harbours bacterial organisms and products. Inflammation in turn induces the secretion of some gut peptides — hormonal messengers that relay signals from the gut to distant tissues, including immune cells. Preliminary data suggest that the increased action of a gut hormone known as glucose-dependent insulinotropic polypeptide (GIP) suppresses inflammation, whereas reduced or complete absence of GIP has the contrary effect, with adverse consequences for metabolism and accelerated development of atherosclerosis. There are currently multiple drug development programs under way to explore whether modulation of GIP activity might be a useful therapeutic approach to treat metabolic disorders such as diabetes and obesity. This project aims to understand how GIP controls inflammation in adipose tissue immune cells and in blood vessels susceptible to the development of atherosclerosis. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Sinai Health System
|
|
|
|
65679f6e212eaade2e0f055f
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20180088220002
|
108822
|
3
|
Far East Asia, regional
|
Far East Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.008217
|
0
|
0
|
0
|
0.008217
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMPROVING THE IMPLEMENTATION O...F TOBACCO TAXATION IN SOUTHEAST ASIA
more
|
Improving the implementation o...f tobacco taxation in Southeast Asia
more
|
Tobacco is a significant contr...ibutor to the rising global burden of non-communicable diseases. The Framework Convention on Tobacco Control, the implementation of which is a specific target (3.a) of the 2030 Sustainable Development Goals, recognizes that raising taxes is the most cost-effective tobacco control measure. However, tobacco tax evasion and the illicit tobacco trade can undermine the effective implementation of tobacco taxes. In 2013, a landmark package of tobacco tax reforms implemented in the Philippines raised taxes by 825%, leading to declines in smoking levels, particularly among the young and the poor. The revenue raised by this initiative paid for health insurance premiums for 14.7 million poor families. The Philippines is one of the highest consumers of illicit cigarettes, and prevalence rates are still high at 23%. Researchers have shown that this illicit trade undermines price and tax controls on tobacco and must be addressed for further momentum on tobacco tax reform. This project hypothesizes that the implementation of tobacco taxation in the Philippines can be improved by strengthening the local evidence base on tobacco tax evasion. Implemented by the Ateneo School of Government in Quezon City, Philippines, it will address the knowledge gaps on illicit trade dynamics that can undermine policy discussions on effective tobacco control. The project will also foster a network of economics researchers in the region who can apply methodological tools and gender-responsive policy analysis towards generating reliable evidence to inform tobacco control policy development. The research will generate independent data on the level and effect of tobacco tax evasion for the Philippines and, through the research fellow network, provide support for similar reform across Southeast Asia. This project is funded through the Economics of Tobacco Control Research Initiative, a co-funding partnership between IDRC and Cancer Research UK, launched in October 2017.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Ateneo de Manila University (Q...uezon City), Inc.
more
|
|
|
|
65679f6e212eaade2e0f0560
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20180088220003
|
108822
|
3
|
Far East Asia, regional
|
Far East Asia
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.00258
|
0
|
0
|
0
|
0.00258
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMPROVING THE IMPLEMENTATION O...F TOBACCO TAXATION IN SOUTHEAST ASIA
more
|
Improving the implementation o...f tobacco taxation in Southeast Asia
more
|
Tobacco is a significant contr...ibutor to the rising global burden of non-communicable diseases. The Framework Convention on Tobacco Control, the implementation of which is a specific target (3.a) of the 2030 Sustainable Development Goals, recognizes that raising taxes is the most cost-effective tobacco control measure. However, tobacco tax evasion and the illicit tobacco trade can undermine the effective implementation of tobacco taxes. In 2013, a landmark package of tobacco tax reforms implemented in the Philippines raised taxes by 825%, leading to declines in smoking levels, particularly among the young and the poor. The revenue raised by this initiative paid for health insurance premiums for 14.7 million poor families. The Philippines is one of the highest consumers of illicit cigarettes, and prevalence rates are still high at 23%. Researchers have shown that this illicit trade undermines price and tax controls on tobacco and must be addressed for further momentum on tobacco tax reform. This project hypothesizes that the implementation of tobacco taxation in the Philippines can be improved by strengthening the local evidence base on tobacco tax evasion. Implemented by the Ateneo School of Government in Quezon City, Philippines, it will address the knowledge gaps on illicit trade dynamics that can undermine policy discussions on effective tobacco control. The project will also foster a network of economics researchers in the region who can apply methodological tools and gender-responsive policy analysis towards generating reliable evidence to inform tobacco control policy development. The research will generate independent data on the level and effect of tobacco tax evasion for the Philippines and, through the research fellow network, provide support for similar reform across Southeast Asia. This project is funded through the Economics of Tobacco Control Research Initiative, a co-funding partnership between IDRC and Cancer Research UK, launched in October 2017.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Ateneo de Manila University (Q...uezon City), Inc.
more
|
|
|
|
65679f6f212eaade2e0f0561
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320003
|
109132
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.311027
|
0.102707
|
0
|
0
|
0.311027
|
0.102707
|
0
|
0.311027
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
22000
|
Donor country-based NGO
|
African Population and Health ...Research Centre
more
|
|
|
|
65679f6f212eaade2e0f0562
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320004
|
109132
|
3
|
Kenya
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.08133
|
0.018856
|
0
|
0
|
0.08133
|
0.018856
|
0
|
0.08133
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
23000
|
Developing country-based NGO
|
Wits Health Consortium (Propri...etary) Ltd.
more
|
|
|
|
65679f70212eaade2e0f0563
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091500003
|
109150
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.037153
|
0
|
0
|
0
|
0.037153
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMMUNOMETABOLIC ROLES AND THER...APEUTIC POTENTIAL OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
more
|
Immunometabolic roles and ther...apeutic potential of glucose-dependent insulinotropic polypeptide (GIP)
more
|
Obesity, type 2 diabetes, and ...cardiovascular disease share common features, including inflammation in multiple tissues. Inflammation arising in the context of diabetes or obesity is thought to contribute to some of the complications of these disorders, including increased risk of cancer and, most notably, higher rates of heart attacks and strokes. Inflammation may arise in part from the gut, which harbours bacterial organisms and products. Inflammation in turn induces the secretion of some gut peptides — hormonal messengers that relay signals from the gut to distant tissues, including immune cells. Preliminary data suggest that the increased action of a gut hormone known as glucose-dependent insulinotropic polypeptide (GIP) suppresses inflammation, whereas reduced or complete absence of GIP has the contrary effect, with adverse consequences for metabolism and accelerated development of atherosclerosis. There are currently multiple drug development programs under way to explore whether modulation of GIP activity might be a useful therapeutic approach to treat metabolic disorders such as diabetes and obesity. This project aims to understand how GIP controls inflammation in adipose tissue immune cells and in blood vessels susceptible to the development of atherosclerosis. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Sinai Health System
|
|
|
|
65679f70212eaade2e0f0564
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091500004
|
109150
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.003378
|
0
|
0
|
0
|
0.003378
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMMUNOMETABOLIC ROLES AND THER...APEUTIC POTENTIAL OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
more
|
Immunometabolic roles and ther...apeutic potential of glucose-dependent insulinotropic polypeptide (GIP)
more
|
Obesity, type 2 diabetes, and ...cardiovascular disease share common features, including inflammation in multiple tissues. Inflammation arising in the context of diabetes or obesity is thought to contribute to some of the complications of these disorders, including increased risk of cancer and, most notably, higher rates of heart attacks and strokes. Inflammation may arise in part from the gut, which harbours bacterial organisms and products. Inflammation in turn induces the secretion of some gut peptides — hormonal messengers that relay signals from the gut to distant tissues, including immune cells. Preliminary data suggest that the increased action of a gut hormone known as glucose-dependent insulinotropic polypeptide (GIP) suppresses inflammation, whereas reduced or complete absence of GIP has the contrary effect, with adverse consequences for metabolism and accelerated development of atherosclerosis. There are currently multiple drug development programs under way to explore whether modulation of GIP activity might be a useful therapeutic approach to treat metabolic disorders such as diabetes and obesity. This project aims to understand how GIP controls inflammation in adipose tissue immune cells and in blood vessels susceptible to the development of atherosclerosis. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
11000
|
Donor Government
|
Sinai Health System
|
|
|
|
65679f70212eaade2e0f0565
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091510004
|
109151
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.037534
|
0
|
0
|
0
|
0.037534
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
G PROTEIN FUNCTIONAL SELECTIVI...TY IN METABOLIC DISORDERS
more
|
G protein functional selectivi...ty in metabolic disorders
more
|
Type 2 diabetes is a metabolic... disease characterized by elevated circulating sugar levels that result from reduced insulin secretion from pancreatic beta cells and reduced sensitivity to insulin. Current treatments are effective in reversing many of the symptoms, but they do not stop the progression of the metabolic dysfunction. As a result, the vast majority of patients with diabetes will die from a heart attack or stroke, and the disease remains the main cause of blindness, kidney failure, and non-traumatic amputations. There is an urgent need to develop new treatments. Both genetic and functional studies have identified G protein-coupled receptors (GPCR) and regulators of G protein signaling expressed in beta cells as potential targets for the development of new treatments. The value of GPCR-targeted therapy for type 2 diabetes has been demonstrated by drugs targeting the glucagon-like peptide-1 (GLP1) receptor, but various side effects accompany their use, including nausea, hypoglycemic episodes, and no long-term restoration of beta cell function. An underlying cause of these undesirable effects relates to the fact that each GPCR can engage several signaling pathways that are responsible for their different actions. Recent progress in GPCR studies revealed that it should be possible to design drugs that selectively regulate the therapeutically relevant pathways while sparing those responsible for the adverse effects. For this purpose, a better understanding of the molecular determinants controlling the different pathways engaged by a given GPCR and its cognate G proteins is needed. Combining structure-based in-silico modelling with biochemical/biophysical assays, this project aims to identify protein partners and function/specificity determinants to probe the role of the individual signaling pathways engaged by the GLP1 receptor that will allow the development of more efficacious and safer drugs against type 2 diabetes. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Université de Montréal
|
|
|
|
65679f70212eaade2e0f0566
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091510005
|
109151
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.003415
|
0
|
0
|
0
|
0.003415
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
G PROTEIN FUNCTIONAL SELECTIVI...TY IN METABOLIC DISORDERS
more
|
G protein functional selectivi...ty in metabolic disorders
more
|
Type 2 diabetes is a metabolic... disease characterized by elevated circulating sugar levels that result from reduced insulin secretion from pancreatic beta cells and reduced sensitivity to insulin. Current treatments are effective in reversing many of the symptoms, but they do not stop the progression of the metabolic dysfunction. As a result, the vast majority of patients with diabetes will die from a heart attack or stroke, and the disease remains the main cause of blindness, kidney failure, and non-traumatic amputations. There is an urgent need to develop new treatments. Both genetic and functional studies have identified G protein-coupled receptors (GPCR) and regulators of G protein signaling expressed in beta cells as potential targets for the development of new treatments. The value of GPCR-targeted therapy for type 2 diabetes has been demonstrated by drugs targeting the glucagon-like peptide-1 (GLP1) receptor, but various side effects accompany their use, including nausea, hypoglycemic episodes, and no long-term restoration of beta cell function. An underlying cause of these undesirable effects relates to the fact that each GPCR can engage several signaling pathways that are responsible for their different actions. Recent progress in GPCR studies revealed that it should be possible to design drugs that selectively regulate the therapeutically relevant pathways while sparing those responsible for the adverse effects. For this purpose, a better understanding of the molecular determinants controlling the different pathways engaged by a given GPCR and its cognate G proteins is needed. Combining structure-based in-silico modelling with biochemical/biophysical assays, this project aims to identify protein partners and function/specificity determinants to probe the role of the individual signaling pathways engaged by the GLP1 receptor that will allow the development of more efficacious and safer drugs against type 2 diabetes. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Université de Montréal
|
|
|
|
65679f71212eaade2e0f0567
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091530004
|
109153
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.03769
|
0
|
0
|
0
|
0.03769
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
METABOLIC AND CHROMATIN REPROG...RAMMING OF HEMATOPOIETIC STEM CELLS (HSC) DURING DAY-NIGHT OSCILLATIONS AND AGING
more
|
Metabolic and chromatin reprog...ramming of hematopoietic stem cells (HSC) during day-night oscillations and aging
more
|
Humans have enormous demands f...or blood production. Alterations in the functioning of the human blood system lie at the heart of many diseases, including cancer, infections, and auto-immune disorders. With age, human blood production changes and immune function is decreased. There is a need to improve our understanding of how our blood system develops from the rare hematopoietic stem cells (HSC) that originate all blood cells, and how aging disrupts this process. This information is critical to develop new therapies against many diseases that originate from abnormal immune cell functioning and to potentially alleviate and/or reverse accelerated decline in HSC function. Previous studies have shown that melatonin is critical to the day/night oscillation pattern that controls the switch HSCs make between the generation of mature blood cells and their replenishment. They also show that sphingolipids govern HSC function and the generation of mature blood cells. Melatonin and sphingolipids are therefore linked, and their levels change with age. This project will use state-of-the-art assays to study normal human blood cells as well as genetically engineered mice to investigate whether these molecules are behind the age-related decline in HSC function. The project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University Health Network/Rés...eau universitaire de santé
more
|
|
|
|
65679f71212eaade2e0f0568
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091530005
|
109153
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.00343
|
0
|
0
|
0
|
0.00343
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
METABOLIC AND CHROMATIN REPROG...RAMMING OF HEMATOPOIETIC STEM CELLS (HSC) DURING DAY-NIGHT OSCILLATIONS AND AGING
more
|
Metabolic and chromatin reprog...ramming of hematopoietic stem cells (HSC) during day-night oscillations and aging
more
|
Humans have enormous demands f...or blood production. Alterations in the functioning of the human blood system lie at the heart of many diseases, including cancer, infections, and auto-immune disorders. With age, human blood production changes and immune function is decreased. There is a need to improve our understanding of how our blood system develops from the rare hematopoietic stem cells (HSC) that originate all blood cells, and how aging disrupts this process. This information is critical to develop new therapies against many diseases that originate from abnormal immune cell functioning and to potentially alleviate and/or reverse accelerated decline in HSC function. Previous studies have shown that melatonin is critical to the day/night oscillation pattern that controls the switch HSCs make between the generation of mature blood cells and their replenishment. They also show that sphingolipids govern HSC function and the generation of mature blood cells. Melatonin and sphingolipids are therefore linked, and their levels change with age. This project will use state-of-the-art assays to study normal human blood cells as well as genetically engineered mice to investigate whether these molecules are behind the age-related decline in HSC function. The project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University Health Network/Rés...eau universitaire de santé
more
|
|
|
|
65679f71212eaade2e0f0569
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091540003
|
109154
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.038548
|
0
|
0
|
0
|
0.038548
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
THE ROLE OF IRON HOMEOSTASIS I...N THE MICROBIOME MEDIATED MODULATION OF METABOLIC SYNDROME
more
|
The role of iron homeostasis i...n the microbiome mediated modulation of metabolic syndrome
more
|
A link has been recognized bet...ween iron overload and metabolic syndrome (MetS), a health disorder that greatly increases the risk of many chronic illnesses such as diabetes and heart disease. MetS is also associated with a modified microbiome, suggesting a causative relationship. Nevertheless, research into the mechanisms leading to metabolic dysfunction after iron overload and dysbiosis (a microbial imbalance) is lacking. This project is designed to examine the general hypothesis that iron-mediated gut dysbiosis has a negative impact on peripheral metabolism. The research team will characterize changes in gut microbiota composition upon iron overload in MetS patients and in mouse models of altered iron status and distribution, verify the functional significance of this alteration via fecal transplantation, and examine cellular mechanisms of iron action in a unique three-dimensional artificial gut model. New knowledge derived from these studies may allow for novel diagnostic and therapeutic approaches related to bacterial signatures and mediators that penetrate the gut and influence peripheral metabolic status in patients with MetS. The project will be led by York University in Canada and the Technion Faculty of Medicine, Israel, in collaboration with Srinakharinwirot University in Thailand. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
York University
|
|
|
|
65679f71212eaade2e0f056a
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091540004
|
109154
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.003504
|
0
|
0
|
0
|
0.003504
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
THE ROLE OF IRON HOMEOSTASIS I...N THE MICROBIOME MEDIATED MODULATION OF METABOLIC SYNDROME
more
|
The role of iron homeostasis i...n the microbiome mediated modulation of metabolic syndrome
more
|
A link has been recognized bet...ween iron overload and metabolic syndrome (MetS), a health disorder that greatly increases the risk of many chronic illnesses such as diabetes and heart disease. MetS is also associated with a modified microbiome, suggesting a causative relationship. Nevertheless, research into the mechanisms leading to metabolic dysfunction after iron overload and dysbiosis (a microbial imbalance) is lacking. This project is designed to examine the general hypothesis that iron-mediated gut dysbiosis has a negative impact on peripheral metabolism. The research team will characterize changes in gut microbiota composition upon iron overload in MetS patients and in mouse models of altered iron status and distribution, verify the functional significance of this alteration via fecal transplantation, and examine cellular mechanisms of iron action in a unique three-dimensional artificial gut model. New knowledge derived from these studies may allow for novel diagnostic and therapeutic approaches related to bacterial signatures and mediators that penetrate the gut and influence peripheral metabolic status in patients with MetS. The project will be led by York University in Canada and the Technion Faculty of Medicine, Israel, in collaboration with Srinakharinwirot University in Thailand. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
York University
|
|
|
|
65679f71212eaade2e0f056b
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091550004
|
109155
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.038592
|
0
|
0
|
0
|
0.038592
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
TRANSCRIPTION FACTOR INTERPLAY... AS A DRIVING FORCE IN THE HEPATIC RESPONSE TO FASTING AND ITS DYSREGULATION IN METABOLIC DISEASE
more
|
Transcription factor interplay... as a driving force in the hepatic response to fasting and its dysregulation in metabolic disease
more
|
Metabolic diseases, including ...diabetes, obesity, and non-alcoholic fatty liver disease are reaching epidemic levels worldwide. Improper cellular energy production, storage, and use underlie many of these conditions. The enzymes that control glucose, fat, and ketone body production in the liver are under the control of numerous proteins called transcription factors. In response to fasting, a specific series of transcription factors are required to ensure proper activation of the enzymes that are important for maintaining fuel levels in the absence of an external food source. In this project, researchers will use specific gene knockout mouse models of these transcription factors, in combination with state-of-the-art DNA and RNA sequencing technologies, to uncover the importance of these transcription factors in modifying the basic physiologic response to fasting and how these are modified in disease. The team will also test novel small molecules that target these transcription factors for their ability to restore the proper fasting response in a mouse model of diet-induced obesity. The project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
|
|
65679f71212eaade2e0f056c
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091550005
|
109155
|
3
|
Middle East, regional
|
Middle East
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.003512
|
0
|
0
|
0
|
0.003512
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
TRANSCRIPTION FACTOR INTERPLAY... AS A DRIVING FORCE IN THE HEPATIC RESPONSE TO FASTING AND ITS DYSREGULATION IN METABOLIC DISEASE
more
|
Transcription factor interplay... as a driving force in the hepatic response to fasting and its dysregulation in metabolic disease
more
|
Metabolic diseases, including ...diabetes, obesity, and non-alcoholic fatty liver disease are reaching epidemic levels worldwide. Improper cellular energy production, storage, and use underlie many of these conditions. The enzymes that control glucose, fat, and ketone body production in the liver are under the control of numerous proteins called transcription factors. In response to fasting, a specific series of transcription factors are required to ensure proper activation of the enzymes that are important for maintaining fuel levels in the absence of an external food source. In this project, researchers will use specific gene knockout mouse models of these transcription factors, in combination with state-of-the-art DNA and RNA sequencing technologies, to uncover the importance of these transcription factors in modifying the basic physiologic response to fasting and how these are modified in disease. The team will also test novel small molecules that target these transcription factors for their ability to restore the proper fasting response in a mouse model of diet-induced obesity. The project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
The Governing Council of the U...niversity of Toronto
more
|
|
|
|
65679f72212eaade2e0f056d
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20180088250001
|
108825
|
3
|
Nigeria
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.035498
|
0
|
0
|
0
|
0.035498
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
THE ECONOMICS OF TOBACCO CONTR...OL IN NIGERIA: FOSTERING AN EFFECTIVE TOBACCO CONTROL POLICY IMPLEMENTATION IN NIGERIA
more
|
The Economics of Tobacco Contr...ol in Nigeria: Fostering an Effective Tobacco Control Policy Implementation in Nigeria
more
|
Tobacco is a significant contr...ibutor to the rising global burden of non-communicable diseases. The Framework Convention on Tobacco Control, the implementation of which is a specific target (3.a) of the 2030 Sustainable Development Goals, recognizes that raising taxes is the most cost-effective tobacco control measure. However, this measure is underused in many countries. Nigeria has one of the largest populations of tobacco users in West Africa (approximately 3.5 million people), yet its fiscal policies for tobacco control appear weak. As recently as June 2018, the Nigerian government approved excise tax rates amounting to a tax burden of 17.3% (relative to the 75% benchmark recommended by the World Health Organization). This new tax rate is also far from the 50% benchmark adopted by the Economic Community of West African States, the regional trade bloc. This project hypothesizes that there is a gap in knowledge among policymakers on the optimal tobacco tax rates and structure for Nigeria. Thus, the project's goals are to: estimate the optimal tobacco tax rates and structure, assess the economic costs and impact of tobacco use across different groups (women, low-income groups, and sub-national regions), and identify the impact of tax changes on illicit trade as well as cost-effective measures of curbing illicit trade on tobacco products in Nigeria. The findings of this proposed project will therefore provide policymakers with rigorous, quantitative evidence about tobacco tax impacts in the Nigerian context. The project will be implemented by an IDRC-supported think tank, the Centre for the Studies of the Economies of Africa. This project is funded through the Economics of Tobacco Control Research Initiative, a five-year co-funding partnership between IDRC and Cancer Research UK that was launched in October 2017.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
3
|
I.2.a. Health, General
|
23000
|
Developing country-based NGO
|
Centre for the Study of the Ec...onomies of Africa
more
|
|
|
|
65679f72212eaade2e0f056e
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20180088220001
|
108822
|
3
|
Philippines
|
Far East Asia
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.043185
|
0
|
0
|
0
|
0.043185
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
IMPROVING THE IMPLEMENTATION O...F TOBACCO TAXATION IN SOUTHEAST ASIA
more
|
Improving the implementation o...f tobacco taxation in Southeast Asia
more
|
Tobacco is a significant contr...ibutor to the rising global burden of non-communicable diseases. The Framework Convention on Tobacco Control, the implementation of which is a specific target (3.a) of the 2030 Sustainable Development Goals, recognizes that raising taxes is the most cost-effective tobacco control measure. However, tobacco tax evasion and the illicit tobacco trade can undermine the effective implementation of tobacco taxes. In 2013, a landmark package of tobacco tax reforms implemented in the Philippines raised taxes by 825%, leading to declines in smoking levels, particularly among the young and the poor. The revenue raised by this initiative paid for health insurance premiums for 14.7 million poor families. The Philippines is one of the highest consumers of illicit cigarettes, and prevalence rates are still high at 23%. Researchers have shown that this illicit trade undermines price and tax controls on tobacco and must be addressed for further momentum on tobacco tax reform. This project hypothesizes that the implementation of tobacco taxation in the Philippines can be improved by strengthening the local evidence base on tobacco tax evasion. Implemented by the Ateneo School of Government in Quezon City, Philippines, it will address the knowledge gaps on illicit trade dynamics that can undermine policy discussions on effective tobacco control. The project will also foster a network of economics researchers in the region who can apply methodological tools and gender-responsive policy analysis towards generating reliable evidence to inform tobacco control policy development. The research will generate independent data on the level and effect of tobacco tax evasion for the Philippines and, through the research fellow network, provide support for similar reform across Southeast Asia. This project is funded through the Economics of Tobacco Control Research Initiative, a co-funding partnership between IDRC and Cancer Research UK, launched in October 2017.
more
|
|
12110
|
Health policy and administrati...ve management
more
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Ateneo de Manila University (Q...uezon City), Inc.
more
|
|
|
|
65679f73212eaade2e0f056f
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320001
|
109132
|
3
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.062205
|
0.020541
|
0
|
0
|
0.062205
|
0.020541
|
0
|
0.062205
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
22000
|
Donor country-based NGO
|
African Population and Health ...Research Centre
more
|
|
|
|
65679f73212eaade2e0f0570
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320002
|
109132
|
3
|
South Africa
|
South of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.02711
|
0.006285
|
0
|
0
|
0.02711
|
0.006285
|
0
|
0.02711
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
23000
|
Developing country-based NGO
|
Wits Health Consortium (Propri...etary) Ltd.
more
|
|
|
|
65679f73212eaade2e0f0571
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320005
|
109132
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.124411
|
0.041083
|
0
|
0
|
0.124411
|
0.041083
|
0
|
0.124411
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
22000
|
Donor country-based NGO
|
African Population and Health ...Research Centre
more
|
|
|
|
65679f74212eaade2e0f0572
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320006
|
109132
|
3
|
Tanzania
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.08133
|
0.018856
|
0
|
0
|
0.08133
|
0.018856
|
0
|
0.08133
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
23000
|
Developing country-based NGO
|
Wits Health Consortium (Propri...etary) Ltd.
more
|
|
|
|
65679f74212eaade2e0f0573
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091540005
|
109154
|
3
|
Thailand
|
Far East Asia
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.040814
|
0
|
0
|
0
|
0.040814
|
0
|
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
THE ROLE OF IRON HOMEOSTASIS I...N THE MICROBIOME MEDIATED MODULATION OF METABOLIC SYNDROME
more
|
The role of iron homeostasis i...n the microbiome mediated modulation of metabolic syndrome
more
|
A link has been recognized bet...ween iron overload and metabolic syndrome (MetS), a health disorder that greatly increases the risk of many chronic illnesses such as diabetes and heart disease. MetS is also associated with a modified microbiome, suggesting a causative relationship. Nevertheless, research into the mechanisms leading to metabolic dysfunction after iron overload and dysbiosis (a microbial imbalance) is lacking. This project is designed to examine the general hypothesis that iron-mediated gut dysbiosis has a negative impact on peripheral metabolism. The research team will characterize changes in gut microbiota composition upon iron overload in MetS patients and in mouse models of altered iron status and distribution, verify the functional significance of this alteration via fecal transplantation, and examine cellular mechanisms of iron action in a unique three-dimensional artificial gut model. New knowledge derived from these studies may allow for novel diagnostic and therapeutic approaches related to bacterial signatures and mediators that penetrate the gut and influence peripheral metabolic status in patients with MetS. The project will be led by York University in Canada and the Technion Faculty of Medicine, Israel, in collaboration with Srinakharinwirot University in Thailand. This project was selected for funding through the fifth research competition of the Joint Canada-Israel Health Research Program. This initiative is a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.
more
|
|
12182
|
Medical research
|
3
|
I.2.a. Health, General
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
York University
|
|
|
|
65679f74212eaade2e0f0574
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320007
|
109132
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.124411
|
0.041083
|
0
|
0
|
0.124411
|
0.041083
|
0
|
0.124411
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
22000
|
Donor country-based NGO
|
African Population and Health ...Research Centre
more
|
|
|
|
65679f74212eaade2e0f0575
|
2020
|
Canada
|
International Development Rese...arch Centre
more
|
20190091320008
|
109132
|
3
|
Uganda
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.08133
|
0.018856
|
0
|
0
|
0.08133
|
0.018856
|
0
|
0.08133
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DEVELOPING A PACKAGE OF EFFECT...IVE REGULATORY INTERVENTIONS FOR HEALTHIER FOOD ENVIRONMENTS IN KENYA, TANZANIA AND UGANDA
more
|
Developing a package of effect...ive regulatory interventions for healthier food environments in Kenya, Tanzania and Uganda
more
|
Low and middle-income countrie...s are experiencing the burden of nutrition-related non-communicable diseases (NCDs) such as diabetes, largely driven by increasingly unhealthy food environments. Although there is growing international consensus on the policy actions (in particular fiscal and regulatory policies) needed to create healthy food environments and prevent nutrition-related NCDs, few countries in Africa have the local evidence to motivate action or the capacity to adopt such policy interventions. The overarching goal of this project is to identify context-relevant priority actions that promote healthy food consumption patterns and facilitate knowledge translation pathways to prevent nutrition-related NCDs in Kenya, Tanzania, and Uganda. The project will mainly adapt methodological approaches developed by the International Network for Food and Obesity NCDs Research Monitoring and Action Support (INFORMAS), a global network of public-interest organizations and researchers that monitors, benchmarks, and supports public and private sector actions to increase healthy food environments. More than 35 countries have implemented various INFORMAS approaches, some funded by IDRC. The project will also estimate the economic costs of policy inaction and the political and legal feasibility of potential policy and regulatory interventions for improving food environments. This project will be funded through the Global Regulatory and Fiscal Capacity Building Program, a multi-agency parallel-funding partnership between IDRC, the Swiss Agency for Development and Cooperation, the OPEC Fund for International Development, the International Development Law Organization, and the World Health Organization.
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
3
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
23000
|
Developing country-based NGO
|
Wits Health Consortium (Propri...etary) Ltd.
more
|
|
|
|
65679f75212eaade2e0f0576
|
2017
|
EU Institutions
|
Commission of the European Com...munities
more
|
2013000613004
|
SCR.CTR.372830
|
3
|
Tunisia
|
North of Sahara
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.0420471
|
0
|
0
|
0
|
0.0420471
|
|
0
|
0
|
0
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
ETUDE D'IMPACT DE LA POLLUTION... INDUSTRIELLE SUR LA SANTÉ HUMAINE À GABÈS
more
|
Etude d'impact de la pollution... industrielle sur la santé humaine à Gabès
more
|
L'objectif du projet est de r...aliser une étude de cadrage au sujet des impacts de la pollution industrielle sur la santé humaine dans la région de Gabès.
more
|
|
41010
|
Environmental policy and admin...istrative management
more
|
|
IV.1. General Environment Prot...ection
more
|
12000
|
Recipient government
|
Recipient Government
|
|
|
|
65679f75212eaade2e0f0577
|
2017
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2017537217
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00901815
|
0.00901815
|
0
|
0
|
0.00901815
|
0.00901815
|
0
|
0.00901815
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
ETAT DES CONNAISSANCES SUR L'I...MPACT SANITAIRE DES POLLENS ET MOISISSURES ALLERGISANTS DE L'AIR AMBIANT
more
|
Etat des connaissances sur l'i...mpact sanitaire des pollens et moisissures allergisants de l'air ambiant
more
|
THEME GEST_SUD (ECOBIO) : Gest...ion durable écosystèmes du sud
more
|
|
41082
|
Environmental research
|
|
IV.1. General Environment Prot...ection
more
|
11000
|
Donor government
|
Gouvernement du donneur
|
|
|
|
65679f75212eaade2e0f0578
|
2017
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2017536917
|
|
8
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00789088
|
0.00789088
|
0
|
0
|
0.00789088
|
0.00789088
|
0
|
0.00789088
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
ETAT DES CONNAISSANCES SUR L'I...MPACT SANITAIRE DES POLLENS ET MOISISSURES ALLERGISANTS DE L'AIR AMBIANT
more
|
Etat des connaissances sur l'i...mpact sanitaire des pollens et moisissures allergisants de l'air ambiant
more
|
THEME GEST_SUD (ECOBIO) : Gest...ion durable écosystèmes du sud
more
|
|
41082
|
Environmental research
|
|
IV.1. General Environment Prot...ection
more
|
11000
|
Donor government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f0579
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018618717
|
|
1
|
Bolivia
|
South America
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0251188
|
0.0251188
|
0
|
0
|
0.0251188
|
0.0251188
|
0
|
0.0251188
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057a
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018614217
|
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.024589
|
0.024589
|
0
|
0
|
0.024589
|
0.024589
|
0
|
0.024589
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057b
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018615117
|
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057c
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018596717
|
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0352485
|
0.0352485
|
0
|
0
|
0.0352485
|
0.0352485
|
0
|
0.0352485
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057d
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018597417
|
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0136254
|
0.0136254
|
0
|
0
|
0.0136254
|
0.0136254
|
0
|
0.0136254
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057e
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018603617
|
|
1
|
Côte d'Ivoire
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0886472
|
0.0886472
|
0
|
0
|
0.0886472
|
0.0886472
|
0
|
0.0886472
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f76212eaade2e0f057f
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018598017
|
|
1
|
Democratic Republic of the Con...go
more
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0164774
|
0.0164774
|
0
|
0
|
0.0164774
|
0.0164774
|
0
|
0.0164774
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0580
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018637117
|
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00140529
|
0.00140529
|
0
|
0
|
0.00140529
|
0.00140529
|
0
|
0.00140529
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0581
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018622117
|
|
1
|
Ecuador
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0471593
|
0.0471593
|
0
|
0
|
0.0471593
|
0.0471593
|
0
|
0.0471593
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0582
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018622517
|
|
1
|
Ecuador
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.00343071
|
0.00343071
|
0
|
0
|
0.00343071
|
0.00343071
|
0
|
0.00343071
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0583
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018607917
|
|
1
|
Mali
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0107746
|
0.0107746
|
0
|
0
|
0.0107746
|
0.0107746
|
0
|
0.0107746
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0584
|
2018
|
France
|
Ministry of Education, Higher ...education and Research
more
|
2018623517
|
|
1
|
Peru
|
South America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0289585
|
0.0289585
|
0
|
0
|
0.0289585
|
0.0289585
|
0
|
0.0289585
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11000
|
Donor Government
|
Gouvernement du donneur
|
|
|
|
65679f77212eaade2e0f0585
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700235
|
|
1
|
Burkina Faso
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0976482
|
0.0976482
|
0
|
0
|
0.0976482
|
0.0976482
|
|
0.0976482
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
|
65679f78212eaade2e0f0586
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700270
|
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.188759
|
0.188759
|
0
|
0
|
0.188759
|
0.188759
|
|
0.188759
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DIFFUSION, TRANSFERT ET VALORI...SATION DES CONNAISSANCES
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
|
65679f78212eaade2e0f0587
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700271
|
|
1
|
Cameroon
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0103557
|
0.0103557
|
0
|
0
|
0.0103557
|
0.0103557
|
|
0.0103557
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
|
65679f78212eaade2e0f0588
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700315
|
|
1
|
Côte d'Ivoire
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.420131
|
0.420131
|
0
|
0
|
0.420131
|
0.420131
|
|
0.420131
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DIFFUSION, TRANSFERT ET VALORI...SATION DES CONNAISSANCES
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
|
65679f78212eaade2e0f0589
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700317
|
|
1
|
Côte d'Ivoire
|
South of Sahara
|
LMICs
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.552059
|
0.552059
|
0
|
0
|
0.552059
|
0.552059
|
|
0.552059
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
RECHERCHE SCIENTIFIQUE ET TECH...NOLOGIQUE EN SCIENCES DE LA VIE ET DE LA SANTÉ
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
Recherche scientifique et tech...nologique en sciences de la vie et de la santé
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
|
65679f78212eaade2e0f058a
|
2019
|
France
|
Ministry of Foreign Affairs
|
2019064860
|
CUB-19-04
|
8
|
Cuba
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
E01
|
0.000559722
|
0.000559722
|
0
|
0
|
0.000559722
|
0.000559722
|
|
|
|
0.000559722
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
P185 - SCAC - CUBA - BOURSE - ...CRÉDITS D'INTERVENTION DES POSTES - BACE1 COMME CIBLE THÉRAPEUTIQUE DE LA MALADIE D'ALZHEIMER : MODÈLE POUR UNE APPROCH
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - BACE1 comme cible thérapeutique de la maladie d'Alzheimer : modèle pour une approche par fragment de conception d'oligonucléotides modifiés
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - BACE1 comme cible thérapeutique de la maladie d'Alzheimer : modèle pour une approche par fragment de conception d'oligonucléotides modifiés - - Noms des partenaires : UH, Univ Paris Sud Paris Saclay - Site internet :
more
|
|
11420
|
Higher education
|
|
I.1.d. Post-Secondary Educatio...n
more
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65679f78212eaade2e0f058b
|
2019
|
France
|
Ministry of Foreign Affairs
|
2019064863
|
CUB-19-04
|
8
|
Cuba
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
E01
|
0.00279861
|
0.00279861
|
0
|
0
|
0.00279861
|
0.00279861
|
|
|
|
0.00279861
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
P185 - SCAC - CUBA - BOURSE - ...CRÉDITS D'INTERVENTION DES POSTES - ETUDE DE LA STRUCTURE MOLÉCULAIRE FINE DES NANOPARTICULES VSSP UTILISÉES POUR L'IMM
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - Etude de la structure moléculaire fine des nanoparticules VSSP utilisées pour l'immunothérapie contre le cancer
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - Etude de la structure moléculaire fine des nanoparticules VSSP utilisées pour l'immunothérapie contre le cancer - - Noms des partenaires : Finlay IFV, Univ Montpellier - Site internet :
more
|
|
11420
|
Higher education
|
|
I.1.d. Post-Secondary Educatio...n
more
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65679f78212eaade2e0f058c
|
2019
|
France
|
Ministry of Foreign Affairs
|
2019064866
|
CUB-19-04
|
8
|
Cuba
|
Caribbean & Central America
|
UMICs
|
ODA Grants
|
1
|
10
|
110
|
E01
|
0.00223889
|
0.00223889
|
0
|
0
|
0.00223889
|
0.00223889
|
|
|
|
0.00223889
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
P185 - SCAC - CUBA - BOURSE - ...CRÉDITS D'INTERVENTION DES POSTES - EVALUATION DE BIOMARQUEURS PRÉDICTIFS DE LA RÉPONSE AU TRAITEMENT PAR INMUNOTHÉRAPI
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - Evaluation de biomarqueurs prédictifs de la réponse au traitement par inmunothérapie en Oncologie
more
|
P185 - SCAC - Cuba - Bourse - ...Crédits d'intervention des postes - Evaluation de biomarqueurs prédictifs de la réponse au traitement par inmunothérapie en Oncologie - - Noms des partenaires : CIM, Institut Paoli-Calmettes - Site internet :
more
|
|
11420
|
Higher education
|
|
I.1.d. Post-Secondary Educatio...n
more
|
11000
|
Donor Government
|
Donor Government
|
|
|
|
65679f79212eaade2e0f058d
|
2019
|
France
|
Ministry of Education, Higher ...education and Research
more
|
20191700386
|
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
2.27736
|
2.27736
|
0
|
0
|
2.27736
|
2.27736
|
|
2.27736
|
|
|
Other health problems
|
Other health problems Research... and Development
more
|
100
|
DIFFUSION, TRANSFERT ET VALORI...SATION DES CONNAISSANCES
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
Diffusion, transfert et valori...sation des connaissances
more
|
|
12382
|
Research for prevention and co...ntrol of NCDs
more
|
|
I.2.c. Non-communicable diseas...es (NCDs)
more
|
11004
|
Other public entities in donor... country
more
|
Other public entities in donor... country
more
|
|
|
